AI assistant
Sending…
Active Biotech — Major Shareholding Notification 2020
Mar 6, 2020
3133_iss_2020-03-06_d730be6b-37a8-4397-bfa0-b50ff71bec0b.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}

Issuer Active Biotech AB (publ)
Holder
Svenska handelsbanken AB
Instrument
| Instrument | aktie SE0001137985 | |
|---|---|---|
| Before the transaction | ||
| Shares | 6,974,394 | |
| Voting rights | 6,974,394 | |
| Transaction | ||
| Reason for major shareholding notification Buy | ||
| Date | 04/03/2020 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 7,444,512 | |
| Directly held voting rights | 7,444,512 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 5.126 % | |
| Directly held voting rights | 5.126 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.126 % | 7,444,512 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 5.126 % | 7,444,512 |
| Group total holdings |
||
| Voting rights 5.126 |
||
| Percentage of voting rights 5.126 | ||
| Notes (other relevant informations according to law) Innehav inom kapitalförsäkringsdepå |
||
| Published 06/03/2020 10:39 |
||
| Contact | ||
| Name Kjell Hagermo |
||
| Phone 701 82 65 |
Email [email protected] | |

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Active Biotech
Quarterly Report
2026
May 7
Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 17
Annual Report (ESEF)
2026
Apr 1
Audit Report / Information
2026
Feb 12
Audit Report / Information
2026
Feb 12
Share Issue/Capital Change
2026
Jan 30
Share Issue/Capital Change
2026
Jan 30
Regulatory Filings
2026
Jan 21